Gibson Dunn has advised BTG Pactual Strategic Capital and its portfolio company, PSN Group, LLC. McDermott Will & Schulte represented BTG Pactual Strategic Capital (Strat Cap)....
Sale of PSN Group to Hospital for Special Surgery and General Atlantic’s Orthopedic Platform Launch
Roche to Acquire 89bio in $3.5 Billion Merger Agreement
Sidley Austin has advised Roche, and Gibson, Dunn & Crutcher LLP has advised 89bio, Inc. Roche has entered into a definitive merger agreement to acquire 89bio,...
Zebra Technologies Signs Agreement to Acquire Elo Touch Solutions for $1.3 Billion
Kirkland & Ellis has advised Zebra Technologies Corporation on the transaction, and Gibson, Dunn & Crutcher has advised Elo Touch Solutions, Inc. Zebra Technologies Corporation has...
Arrowhead Pharmaceuticals’ Lincense Collaboration Agreement with Sarepta Therapeutics
Gibson Dunn & Crutcher advised Arrowhead Pharmaceuticals, Inc. on the transaction, and Ropes & Gray advised Sarepta Therapeutics. Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced a global...
Bora Pharmaceuticals’ $210 Million Acquisition of Upsher-Smith Laboratories
Gibson, Dunn & Crutcher LLP is representing Bora Pharmaceuticals in its acquisition of Upsher-Smith Laboratories. Bora Pharmaceuticals Co., Ltd. announced the acquisition of Upsher-Smith Laboratories, Inc., a generics manufacturer...
United Therapeutics’ Acquisition of Miromatrix Medical
Gibson, Dunn & Crutcher LLP advised United Therapeutics Corporation on its acquisition of Miromatrix Medical Inc., assisted by Faegre Drinker Biddle & Reath LLP. Piper Sandler...